BMP6 and ocular melanoma: Transcription factor SRY (Sex-Determining Region Y)-Box 9 (Sox9) increased in both treatment groups and at both time points relative to d0, but was significantly down-regulated in BMP6-treated MMs compared to OM controls at 6 weeks (Fig. 7A; n = 6, p < 0.005).